ZELTIQ
ZELTIQ Aesthetics, Inc. was an American medical device company founded in 2007 and headquartered in Sunnyvale, California. The company specialized in non-invasive fat reduction and body contouring technologies using its proprietary cryolipolysis platform, branded as CoolSculpting. The CoolSculpting procedure involves cooling fat cells to a temperature that causes their natural elimination without damaging surrounding tissues, providing a non-surgical alternative to liposuction.
ZELTIQ grew rapidly due to the increasing demand for minimally invasive aesthetic treatments. Its technology received
In 2015, ZELTIQ was acquired by its larger competitor, Johnson & Johnson, in a deal valued at approximately
In 2017, the company was rebranded as Allergan Aesthetics, a division of AbbVie following Allergan’s acquisition
ZELTIQ's innovations have played a pivotal role in popularizing non-invasive cosmetic procedures, and its technology remains